Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry
Giora Weisz(Columbia University Irving Medical Center), Paul S. Teirstein(Scripps Health), Laura Findeiss(American Heart Association), Roxana Mehran(Mount Sinai Hospital), Bret N. Wiechmann(Society of Interventional Radiology), Steven J. Filby(University Hospitals of Cleveland), Dimitris K. Kyriazis(University of South Alabama), Paolo Danna(Luigi Sacco Hospital), Jeffrey W. Moses(Good Samaritan University Hospital), Matthew J. Price(Scripps Clinic), William F. Fearon(Stanford University), Barry S. Weinstock(Regional Medical Center), Craig Walker(Cardiovascular Institute of the South), Martin B. Leon(Columbia University Irving Medical Center), Naveen Sachdev(St. Vincent's Birmingham), David E. Allie, Kishor Vora(Owensboro Health), Mauricio G. Cohen(Santa Ana College)
Cited by 44
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k